Experience with high-dose immunosuppressive therapy followed by transplantation of autologous stem hemopoietic cells in patients with multiple sclerosis

Terapevticheskii Arkhiv

Volumn 74, Issue 7, 2002, Pages 35-38

  Rossiev, V A ^a   Makarov, S V ^a   Alexandrova, I Ya ^a   Dolgikh, G T ^a   Lipshina, S R ^a   Stukalova, T A ^a   Trushina, O A ^a   Fedorova, E Yu ^a   Lipina, L N ^a   Sivak, V F ^a   Korenev, P P ^a   Murashov, B F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; AUTOTRANSPLANTATION; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE SCLEROSIS;

ADOLESCENT; ADULT; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MULTIPLE SCLEROSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 11244323914     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Hafler D. A., Wemer H. L. Immunological mechanisms and therapy in multiple sclerosis. Immunol Rev. 1995; 14:475-77.